About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 
Home   |   Customers   |   Vendors   |   Libraries  
The Code of Federal Regulations (CFR) annual edition is the codification of the general and permanent rules published in the Federal Register by the departments and agencies of the Federal Government produced by the Office of the Federal Register (OFR) and the Government Publishing Office.


Parallel Table of Authorities and Rules for the Code of Federal Regulations and the United States Code
Text | PDF

Find, review, and submit comments on Federal rules that are open for comment and published in the Federal Register using Regulations.gov.

Purchase individual CFR titles from the U.S. Government Online Bookstore.

Find issues of the CFR (including issues prior to 1996) at a local Federal depository library.

[1]
 
 

Electronic Code of Federal Regulations

Electronic Code of Federal Regulations

e-CFR data is current as of August 27, 2015

Title 21Chapter ISubchapter DPart 341


TITLE 21—Food and Drugs

CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)

SUBCHAPTER D—DRUGS FOR HUMAN USE

PART 341—COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE

rule

Subpart A—GENERAL PROVISIONS

§341.1
Scope.
§341.3
Definitions.
rule

Subpart B—ACTIVE INGREDIENTS

§341.12
Antihistamine active ingredients.
§341.14
Antitussive active ingredients.
§341.16
Bronchodilator active ingredients.
§341.18
Expectorant active ingredient.
§341.20
Nasal decongestant active ingredients.
§341.40
Permitted combinations of active ingredients.
rule

Subpart C—LABELING

§341.70
Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
§341.72
Labeling of antihistamine drug products.
§341.74
Labeling of antitussive drug products.
§341.76
Labeling of bronchodilator drug products.
§341.78
Labeling of expectorant drug products.
§341.80
Labeling of nasal decongestant drug products.
§341.85
Labeling of permitted combinations of active ingredients.
§341.90
Professional labeling.

Need assistance?